Wu Qi, Christensen Laura A, Legerski Randy J, Vasquez Karen M
Department of Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, 1808 Park Road 1-C, Smithville, Texas 78957, USA.
EMBO Rep. 2005 Jun;6(6):551-7. doi: 10.1038/sj.embor.7400418.
DNA interstrand crosslinks (ICLs) present formidable blocks to DNA metabolic processes and must be repaired for cell survival. ICLs are induced in DNA by intercalating compounds such as the widely used therapeutic agent psoralen. In bacteria, both nucleotide excision repair (NER) and homologous recombination are required for the repair of ICLs. The processing of ICLs in mammalian cells is not clearly understood. However, it is known that processing can occur by NER, which for psoralen ICLs can be an error-generating process conducive to mutagenesis. We show here that another repair pathway, mismatch repair (MMR), is also involved in eliminating psoralen ICLs in human cells. MMR deficiency renders cells hypersensitive to psoralen ICLs without diminishing their mutagenic potential, suggesting that MMR does not contribute to error-generating repair, and that MMR may represent a relatively error-free mechanism for processing these lesions in human cells. Thus, enhancement of MMR relative to NER may reduce the mutagenesis caused by DNA ICLs in humans.
DNA链间交联(ICLs)对DNA代谢过程构成了巨大障碍,为了细胞存活必须进行修复。ICLs由嵌入化合物如广泛使用的治疗剂补骨脂素在DNA中诱导产生。在细菌中,核苷酸切除修复(NER)和同源重组都是修复ICLs所必需的。哺乳动物细胞中ICLs的处理过程尚不清楚。然而,已知处理过程可通过NER发生,对于补骨脂素ICLs而言,这可能是一个有利于诱变的产生错误的过程。我们在此表明,另一种修复途径,错配修复(MMR),也参与消除人类细胞中的补骨脂素ICLs。MMR缺陷使细胞对补骨脂素ICLs高度敏感,而不降低其诱变潜力,这表明MMR对产生错误的修复没有贡献,并且MMR可能代表了一种在人类细胞中处理这些损伤的相对无错误的机制。因此,相对于NER增强MMR可能会减少人类中由DNA ICLs引起的诱变。